Neuronal Nuclear Antibodies (Hu, Ri, Yo, Tr/DNER) IgG by Immunoblot, Serum




Test Mnemonic

HURIYO

CPT Codes

  • 84182 - QTY (4)

LOINC ®

35278-1

Includes

  • Neuronal nuclear Ab Hu, IgG
  • Neuronal nuclear Ab Ri, IgG
  • Neuronal nuclear Ab Yo, IgG
  • Neuronal nuclear Ab Tr/DNER, IgG

Performing Laboratory

ARUP

FDA Category

Laboratory Developed Test


Specimen Requirements

Volume Type Container Collect Temperature Transport Temperature Special Instructions
1 mLSerumSST (Gold) RefrigeratedSeparate serum from cells ASAP or within 2 hours of collection.

Minimum Specimen Requirements

Volume Type Container Collect Temperature Transport Temperature Special Instructions
0.3 mL     

Stability

Environmental Condition Description
RefrigeratedAfter separation from cells: 2 weeks
AmbientAfter separation from cells: 48 hours
FrozenAfter separation from cells: 1 month

Days Performed

Mon, Thu, Sat

Turnaround Time

2 - 5 days

Methodology

Name Description
Immunoblot (IB), Qualitative 

Reference Range

Neuronal Nuc Ab, Hu
Sex Age From Age To Type Range Range Unit
       NormalNegative 
Neuronal Nuc Ab, Ri
Sex Age From Age To Type Range Range Unit
       NormalNegative 
Neuronal Nuc Ab, Tr/DNER
Sex Age From Age To Type Range Range Unit
       NormalNegative 
Neuronal Nuc Ab, Yo
Sex Age From Age To Type Range Range Unit
       NormalNegative 

Special Info

This test may be a reflex from Motor and Sensory Neuropathy Evaluation with Reflex to Titer and Neuronal Immunoblot (SENMOT) or Sensory Neuropathy Antibody Panel with Reflex to Titer and Neuronal Immunoblot (SENNRO). Grossly hemolyzed, heat-inactivated, contaminated, or lipemic specimens will be rejected.

Clinical Info

This assay detects IgG antineuronal antibodies to Hu, Ri, Yo and Tr (DNER) antigens. Antineuronal antibodies serve as markers that aid in discriminating between a true paraneoplastic neurological disorder (PND) and other inflammatory disorders of the nervous system. Anti-Hu (antineuronal nuclear antibody, type I) is associated with small cell lung cancer. Anti-Ri (antineuronal nuclear antibody, type II) is associated with fallopian tube and breast cancer in adults and neuroblastoma in children. Anti-Yo (anti-Purkinje cell cytoplasmic antibody) is associated with ovarian and breast cancer. Anti-Tr(DNER) is associated with Hodgkin’s lymphoma. Presence of one or more of these antineuronal antibodies supports a clinical diagnosis of PND and should lead to a focused search for the underlying neoplasm.